Debate on CGM Use for Non-Diabetics

D

Dr. Peter Attia on podcast with Tim Ferriss.

GlucoseWearables

Quotes From Source

“'Is there a randomized controlled trial...in anything outside of patients with diabetes?'”

Story of claim

The role of CGMs in non-diabetics is debated due to lack of evidence on glucose level significance and absence of trials. Lower average glucose may reduce health risks.

  • Goal: Explore the significance of glucose levels in non-diabetics.
  • Proof: Lower average glucose levels in non-diabetics may correlate with reduced all-cause mortality.
  • Nuances:
    • No randomized controlled trial for CGM use in non-diabetics
    • Hemoglobin A1c above 6.5% indicates diabetes
  • Impact on Life: Potential for non-diabetics to gain insights into lifestyle effects on glucose, though benefits remain speculative without solid evidence.

Investments

  • Price: $100-200 per month for CGM devices
  • Time: 5 minutes daily for device management
  • Effort: Requires analysis of lifestyle impacts on glucose

Risks

Overemphasis on glucose levels may neglect other important health markers.

Alternatives

  • Regular health check-ups and lifestyle assessments

Get Started 🚀

  • Consider the purpose and potential benefits before obtaining a CGM.
  • Discuss with a healthcare provider to assess suitability.
  • Use CGM data to explore personal glucose responses.
  • Balance glucose insights with other health metrics.

Brogevity AI can make mistakes. Check important info.

Reference Video